Clear Search

Books+ Search Results

Subject (Genre): Is
Is Is Not
Legislative hearings
Subject with Hierarchy: Is
Is Is Not
Pharmaceutical industry

Advanced Search

Basic Search
Help
Add a row
Reset

Limit results by

Show Online Results Only
Online Results (31)
1.
Drug shortage health and national security risks : underlying causes and needed reforms : hearing before the Committee on Homeland Security and Governmental Affairs, United States Senate, One Hundred Eighteenth Congress, first session, March 22, 2023
Author
United States. Congress. Senate. Committee on Homeland Security and Governmental Affairs, author
Published
Washington : U.S. Government Publishing Office, 2023.
Location
Library Shelving Facility (LSF) >> Y 4.G 74/9:S.HRG.118-56
Format
Books
2.
The role of pharmacy benefit managers in prescription drug markets : hearing before the Committee on Oversight and Accountability, House of Representatives, One Hundred Eighteenth Congress, first session
Author
United States. Congress. House. Committee on Oversight and Accountability, author
Published
Washington : U.S. Government Publishing Office, 2023.
Location
Library Shelving Facility (LSF) >> Y 4.OV 2:118-36
Format
Books
3.
The complex web of prescription drug prices : examining agency efforts to further competition and increase affordability : hearing before the Special Committee on Aging, United States Senate, One Hundred Sixteenth Congress, first session, Washington, DC, June 19, 2019
Author
United States. Congress. Senate. Special Committee on Aging, author
Published
Washington : U.S. Government Publishing Office, 2022.
Online
https://purl.fdlp.gov/GPO/gpo183063
Location
Yale Internet Resource >> None
Format
Books / Online
4.
Lower drug costs now : expanding access to affordable health care : hearing before the Subcommittee on Health, Employment, Labor, and Pensions of the Committee on Education and Labor, U.S. House of Representatives, One Hundred Seventeenth Congress, first session, hearing held in Washington, DC, May 5, 2021
Author
United States. Congress. House. Committee on Education and Labor. Subcommittee on Health, Employment, Labor, and Pensions, author
Published
Washington : U.S. Government Publishing Office, 2022.
Online
https://purl.fdlp.gov/GPO/gpo182511
Location
Yale Internet Resource >> None
Format
Books / Online
5.
Lower drug costs now : expanding access to affordable health care : hearing before the Subcommittee on Health, Employment, Labor, and Pensions of the Committee on Education and Labor, U.S. House of Representatives, One Hundred Seventeenth Congress, first session, hearing held in Washington, DC, May 5, 2021
Author
United States. Congress. House. Committee on Education and Labor. Subcommittee on Health, Employment, Labor, and Pensions, author
Published
Washington, DC : United States Government Publishing Office, 2022.
Location
Library Shelving Facility (LSF) >> Y 4.ED 8/1:117-11
Format
Books
6.
No time to wait : proposals to lower prescription drug costs : hearing before the Special Committee on Aging, United States Senate, One Hundred Seventeenth Congress, second session, Phoenix, Arizona, April 12, 2022
Author
United States. Congress. Senate. Special Committee on Aging, author
Published
Washington : U.S. Government Publishing Office, 2022.
Location
Library Shelving Facility (LSF) >> Y 4.AG 4:S.HRG.117-249
Format
Books
7.
No time to wait : proposals to lower prescription drug costs : hearing before the Special Committee on Aging, United States Senate, One Hundred Seventeenth Congress, second session, Phoenix, Arizona, April 12, 2022
Author
United States. Congress. Senate. Special Committee on Aging, author
Published
Washington : U.S. Government Publishing Office, 2022.
Online
https://purl.fdlp.gov/GPO/gpo182961
Location
Yale Internet Resource >> None
Format
Books / Online
8.
Profits over consumers : exposing how pharmaceutical companies game the system : hearing before the Subcommittee on Consumer Protection and Commerce of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, September 19, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Consumer Protection and Commerce, author
Published
Washington : U.S. Government Publishing Office, 2022.
Online
https://purl.fdlp.gov/GPO/gpo183702
Location
Yale Internet Resource >> None
Format
Books / Online
9.
Profits over consumers : exposing how pharmaceutical companies game the system : hearing before the Subcommittee on Consumer Protection and Commerce of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, September 19, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Consumer Protection and Commerce, author
Published
Washington : U.S. Government Publishing Office, 2022.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:116-63
Format
Books
10.
Safeguarding pharmaceutical supply chains in a global economy : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, October 30, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2022.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:116-76
Format
Books
11.
Safeguarding pharmaceutical supply chains in a global economy : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, October 30, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2022.
Online
https://purl.fdlp.gov/GPO/gpo186472
Location
Yale Internet Resource >> None
Format
Books / Online
12.
Valeant Pharmaceuticals' business model : the repercussions for patients and the health care system : hearing before the Special Committee on Aging, United States Senate, One Hundred Fourteenth Congress, second session, Washington, DC, April 27, 2016
Author
United States. Congress. Senate. Special Committee on Aging, author
Published
Washington : U.S. Government Publishing Office, 2022.
Online
https://purl.fdlp.gov/GPO/gpo185727
Location
Yale Internet Resource >> None
Format
Books / Online
13.
Valeant Pharmaceuticals' business model : the repercussions for patients and the health care system : hearing before the Special Committee on Aging, United States Senate, One Hundred Fourteenth Congress, second session, Washington, DC, April 27, 2016
Author
United States. Congress. Senate. Special Committee on Aging, author
Published
Washington : U.S. Government Publishing Office, 2022.
Location
Library Shelving Facility (LSF) >> Y 4.AG 4:S.HRG.114-846
Format
Books
14.
Improving drug pricing transparency and lowering prices for American consumers : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, May 21, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2021.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:116-37
Format
Books
15.
Improving drug pricing transparency and lowering prices for American consumers : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, May 21, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2021.
Online
https://purl.fdlp.gov/GPO/gpo156915
Location
Yale Internet Resource >> None
Format
Books / Online
16.
Lowering prescription drug prices : deconstructing the drug supply chain : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, May 9, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington, DC : United States Government Publishing Office, 2021.
Online
https://purl.fdlp.gov/GPO/gpo187077
Location
Yale Internet Resource >> None
Format
Books / Online
17.
Lowering prescription drug prices : deconstructing the drug supply chain : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, May 9, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington, DC : United States Government Publishing Office, 2021.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:116-32
Format
Books
18.
Lowering the cost of prescription drugs : reducing barriers to market competition : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, March 13, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2021.
Online
https://purl.fdlp.gov/GPO/gpo153433
Location
Yale Internet Resource >> None
Format
Books / Online
19.
Lowering the cost of prescription drugs : reducing barriers to market competition : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, March 13, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2021.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:116-17
Format
Books
20.
Making health care more affordable : lowering drug prices and increasing transparency : hearing before the Subcommittee on Health, Employment, Labor and Pensions, Committee on Education and Labor, U.S. House of Representatives, One Hundred Sixteenth Congress, first session : hearing held in Washington, DC, September 26, 2019
Author
United States. Congress. House. Committee on Education and Labor. Subcommittee on Health, Employment, Labor, and Pensions, author
Published
Washington : U.S. Government Publishing Office, 2021.
Online
https://purl.fdlp.gov/GPO/gpo150498
Location
Yale Internet Resource >> None
Format
Books / Online
21.
Making health care more affordable : lowering drug prices and increasing transparency : hearing before the Subcommittee on Health, Employment, Labor and Pensions, Committee on Education and Labor, U.S. House of Representatives, One Hundred Sixteenth Congress, first session : hearing held in Washington, DC, September 26, 2019
Author
United States. Congress. House. Committee on Education and Labor. Subcommittee on Health, Employment, Labor, and Pensions, author
Published
Washington : U.S. Government Publishing Office, 2021.
Location
Library Shelving Facility (LSF) >> Y 4.ED 8/1:116-42
Format
Books
22.
The role of Purdue Pharma and the Sackler family in the opioid epidemic : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, second session, December 17, 2020
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2021.
Location
Library Shelving Facility (LSF) >> KF27 .O96 2020 (LC)
Format
Books
23.
The role of Purdue Pharma and the Sackler family in the opioid epidemic : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, second session, December 17, 2020
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2021.
Online
PDF version
Text version
Location
Yale Internet Resource >> None
Format
Books / Online
24.
The SACKLER Act and other policies to promote accountability for the Sackler family's role in the opioid epidemic : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Seventeenth Congress, first session, June 8, 2021
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2021.
Location
Library Shelving Facility (LSF) >> Y 4.OV 2:117-27
Format
Books
25.
The SACKLER Act and other policies to promote accountability for the Sackler family's role in the opioid epidemic : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Seventeenth Congress, first session, June 8, 2021
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2021.
Online
https://purl.fdlp.gov/GPO/gpo171680
Location
Yale Internet Resource >> None
Format
Books / Online
26.
Prescription drug affordability and innovation : addressing challenges in today's market : hearing before the Committee on Finance, United States Senate, One Hundred Fifteenth Congress, second session, June 26, 2018
Author
United States. Congress. Senate. Committee on Finance, author
Published
Washington : U.S. Government Publishing Office, 2020.
Location
Library Shelving Facility (LSF) >> Y 4.F 49:S.HRG.115-727
Format
Books
27.
Prescription drug affordability and innovation : addressing challenges in today's market : hearing before the Committee on Finance, United States Senate, One Hundred Fifteenth Congress, second session, June 26, 2018
Author
United States. Congress. Senate. Committee on Finance, author
Published
Washington : U.S. Government Publishing Office, 2018.
Online
https://purl.fdlp.gov/GPO/gpo130776
Location
Yale Internet Resource >> None
Format
Books / Online
28.
Priced out of a lifesaving drug : getting answers on the rising cost of insulin : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, April 10, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations, author
Published
Washington : U.S. Government Publishing Office, 2020.
Online
https://purl.fdlp.gov/GPO/gpo146986
Location
Yale Internet Resource >> None
Format
Books / Online
29.
Priced out of a lifesaving drug : getting answers on the rising cost of insulin : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, April 10, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations, author
Published
Washington : U.S. Government Publishing Office, 2020.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:116-25
Format
Books
30.
Priced out of a lifesaving drug : the human impact of rising insulin costs : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, April 2, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations, author
Published
Washington : U.S. Government Publishing Office, 2020.
Online
https://purl.fdlp.gov/GPO/gpo152475
Location
Yale Internet Resource >> None
Format
Books / Online
31.
Priced out of a lifesaving drug : the human impact of rising insulin costs : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, April 2, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations, author
Published
Washington : U.S. Government Publishing Office, 2020.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:116-21
Format
Books
32.
Unsustainable drug prices : hearing before the Committee on Oversight and Reform, House of Representatives
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2020-2021.
Location
Library Shelving Facility (LSF) >> Y 4.OV 2:116-123
Format
Books
33.
Unsustainable drug prices : testimony from the CEOs : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, second session
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2020.
Online
https://purl.fdlp.gov/GPO/gpo149312
Location
Yale Internet Resource >> None
Format
Books / Online
34.
Drug pricing in America : a prescription for change : hearing before the Committee on Finance, United States Senate, One Hundred Sixteenth Congress, first session
Author
United States. Congress. Senate. Committee on Finance, author
Published
Washington : U.S. Government Publishing Office, 2019-
Location
Library Shelving Facility (LSF) >> Y 4.F 49:S.HRG.116-39
Format
Books
35.
Examining implementation of the Compounding Quality Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, January 30, 2018
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2019.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:115-96
Format
Books
36.
Examining implementation of the Compounding Quality Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, January 30, 2018
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2019.
Online
https://purl.fdlp.gov/GPO/gpo116408
Location
Yale Internet Resource >> None
Format
Books / Online
37.
Examining the actions of drug companies in raising prescription drug prices : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, January 29, 2019
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2019.
Location
Library Shelving Facility (LSF) >> Y 4.OV 2:116-01
Format
Books
38.
Examining the actions of drug companies in raising prescription drug prices : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, January 29, 2019
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2019.
Online
PDF version
Text version
Location
Yale Internet Resource >> None
Format
Books / Online
39.
HIV prevention drug : billions in corporate profits after millions in taxpayer investments : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, May 16, 2019
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2019.
Online
PDF version
Text version
Location
Yale Internet Resource >> None
Format
Books / Online
40.
HIV prevention drug : billions in corporate profits after millions in taxpayer investments : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, May 16, 2019
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2019.
Location
Library Shelving Facility (LSF) >> Y 4.OV 2:116-24
Format
Books
41.
The patient perspective : the devastating impacts of skyrocketing drug prices on American families : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, July 26, 2019
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2019.
Location
Library Shelving Facility (LSF) >> Y 4.OV 2:116-55
Format
Books
42.
Competition in the pharmaceutical supply chain : the proposed merger of CVS Health and Aetna : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, second session, February 27, 2018
Author
United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law, author
Published
Washington : U.S. Government Publishing Office, 2018.
Location
Library Shelving Facility (LSF) >> Y 4.J 89/1:115-28
Format
Books
43.
Competition in the pharmaceutical supply chain : the proposed merger of CVS Health and Aetna : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, second session, February 27, 2018
Author
United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law, author
Published
Washington : U.S. Government Publishing Office, 2018.
Online
PDF version
Text version
Location
Yale Internet Resource >> None
Format
Books / Online
44.
Drug pricing in America : a prescription for change : hearing before the Committee on Finance, United States Senate, One Hundred Sixteenth Congress, first session, February 28, 2019
Author
United States. Congress. Senate. Committee on Finance, author
Published
Washington : U.S. Government Publishing Office, 2019.
Online
https://purl.fdlp.gov/GPO/gpo124181
Location
Yale Internet Resource >> None
Format
Books / Online
45.
EpiPen price increases : how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY)
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Children and Families, author
Published
Washington : U.S. Government Publishing Office, 2018.
Online
https://purl.fdlp.gov/GPO/gpo113215
Location
Yale Internet Resource >> None
Format
Books / Online
46.
Developments in the prescription drug market : oversight : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fourteenth Congress, second session, February 4, 2016
Author
United States. Congress. House. Committee on Oversight and Government Reform, author
Published
Washington : U.S. Government Publishing Office, 2017.
Online
http://purl.fdlp.gov/GPO/gpo82526
Location
Yale Internet Resource >> None
Format
Books / Online
47.
Developments in the prescription drug market : oversight : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fourteenth Congress, second session, February 4, 2016
Author
United States. Congress. House. Committee on Oversight and Government Reform, author
Published
Washington : U.S. Government Publishing Office, 2017.
Washington, DC : For sale by the Superintendent of Documents, U.S. Government Publishing Office
Location
Library Shelving Facility (LSF) >> Y 4.G 74/7:114-132
Format
Books
48.
Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017
Author
United States. Congress. House. Committee on Oversight and Government Reform. Subcommittee on Health Care, Benefits, and Administrative Rules, author
Published
Washington : U.S. Government Publishing Office, 2017.
Washington, DC : For sale by the Superintendent of Documents, U.S. Government Publishing Office
Location
Library Shelving Facility (LSF) >> Y 4.G 74/7:115-33
Format
Books
49.
Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017
Author
United States. Congress. House. Committee on Oversight and Government Reform. Subcommittee on Health Care, Benefits, and Administrative Rules, author
Published
Washington : U.S. Government Publishing Office, 2017.
Online
http://purl.fdlp.gov/GPO/gpo86757
Location
Yale Internet Resource >> None
Format
Books / Online
50.
Treating the opioid epidemic : the state of competition in the markets for addiction medication : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fourteenth Congress, second session, September 22, 2016
Author
United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law, author
Published
Washington : U.S. Government Publishing Office, 2017.
Online
http://purl.fdlp.gov/GPO/gpo77020
Location
Yale Internet Resource >> None
Format
Books / Online
51.
Treating the opioid epidemic : the state of competition in the markets for addiction medication : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fourteenth Congress, second session, September 22, 2016
Author
United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law, author
Published
Washington : U.S. Government Publishing Office, 2017.
Washington, DC : For sale by the Superintendent of Documents, U.S. Government Publishing Office
Location
Library Shelving Facility (LSF) >> Y 4.J 89/1:114-97
Format
Books
52.
A continuing investigation into the fungal meningitis outbreak and whether it could have been prevented : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, April 16, 2013
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations, author
Published
Washington : U.S. Government Printing Office, 2015.
Online
http://purl.fdlp.gov/GPO/gpo55617
Location
Yale Internet Resource >> None
Format
Books / Online
53.
Counterfeit drugs : fighting illegal supply chains : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, February 27, 2014
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations, author
Published
Washington : U.S. Government Publishing Office, 2015.
Washington, DC : For sale by the Superintendent of Documents, U.S. Government Publishing Office
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:113-120
Format
Books
54.
Examining drug compounding : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, May 23, 2013
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Printing Office, 2014.
Washington, District of Columbia : For sale by the Superintendent of Documents, U.S. Government Printing Office
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:113-48
Format
Books
55.
Examining drug shortages and recent efforts to address them : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, February 10, 2014
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Printing Office, 2014.
Washington, District of Columbia : For sale by the Superintendent of Documents, U.S. Government Printing Office, [date of distribution not identified]
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:113-117
Format
Books
56.
Reforming the drug compounding regulatory framework : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, July 16, 2013
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Printing Office, 2014.
Washington, District of Columbia : For sale by the Superintendent of Documents, U.S. Government Printing Office
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:113-70
Format
Books
57.
Securing our nation's prescription drug supply chain : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, April 25, 2013
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Printing Office, 2014.
Washington, District of Columbia : For sale by the Superintendent of Documents, U.S. Government Printing Office
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:113-35
Format
Books
58.
Securing the pharmaceutical supply chain : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, first session, on examining the pharmaceutical supply chain, focusing on how the Food and Drug Administration faces challenges overseeing the foreign drug manufacturing supply chain, September 14, 2011
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions, author
Published
Washington : U.S. Government Printing Office, 2014.
Washington, District of Columbia : For sale by the Superintendent of Documents, U.S. Government Printing Office.
Location
Library Shelving Facility (LSF) >> Y 4.L 11/4:S.HRG.112-866
Format
Books
59.
Pay-for-delay deals : limiting competition and costing consumers : hearing before the Subcommittee on Antitrust, Competition Policy and Consumer Rights of the Committee on the Judiciary, United States Senate, One Hundred Thirteenth Congress, first session, July 23, 2013
Author
United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust, Competition Policy, and Consumer Rights, author
Published
Washington : U.S. Government Printing Office, 2013.
Washington, District of Columbia : For sale by the Superintendent of Documents, U.S. Government Printing Office.
Location
Library Shelving Facility (LSF) >> Y 4.J 89/2:S.HRG.113-279
Format
Books
60.
Food and Drug Administration's Critical Path Initiative : hearing before a subcommittee of the Committee on Appropriations, United States Senate; One Hundred Tenth Congress, first session; special hearing: June 1, 2007; Salt Lake City, Utah
Author
United States. Congress. Senate. Committee on Appropriations. Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, author
Published
Washington : U.S. Government Printing Office, 2008.
Online
PDF version
Text version
Location
Yale Internet Resource >> None
Format
Books / Online
61.
Avoiding conflicts of interest at the National Institutes of Health : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Eighth Congress, second session, special hearing, January 22, 2004, Washington, DC
Author
United States. Congress. Senate. Committee on Appropriations. Subcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies, author
Published
Washington : U.S. Government Printing Office : For sale by the Superintendent of Documents, U.S. Government Printing Office, 2004.
Online
PDF version:
Text version:
Location
Yale Internet Resource >> None
Format
Books / Online
62.
Examining issues related to competition in the pharmaceutical marketplace : a review of the FTC report, generic drug entry prior to patent expiration : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, June 13 and October 10, 2002
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington, DC : U.S.Government Printing Office, 2002.
Online
https://purl.fdlp.gov/GPO/gpo89001
Location
Yale Internet Resource >> None
Format
Books / Online
63.
Legislative proposal to increase funding for medical research : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Fifth Congress, first session, special hearing
Author
United States. Congress. Senate. Committee on Appropriations. Subcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies, author
Published
Washington : U.S. Government Printing Office, 1998.
Online
https://purl.fdlp.gov/GPO/gpo93960
Location
Yale Internet Resource >> None
Format
Books / Online
64.
Examining drug shortages and recent efforts to address them : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, February 10, 2014
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
Online
Online book
Location
HathiTrust Digital Library >> Online Resource
Format
Books / Online